HMOX1 and malaria: The functional duality is problematic with respect to developing adjuvant therapies for severe malaria based on induction of HO-1 or administration of CO, and highlights the need to understand better the regulation and function of HO-1 in humans in relation to both promoter polymorphisms and malaria.